Report Detail

Pharma & Healthcare Global Companion Animal Vaccines Market Insights, Forecast to 2025

  • RnM2716528
  • |
  • 04 June, 2019
  • |
  • Global
  • |
  • 112 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Companion animal vaccines are used to stimulate an immune response in pets such as canine, avian and feline. These vaccine products are of various types such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines.
The Canine segment is the most attractive segment, recording an attractiveness index of 1.5 over the forecast period. The segment is projected to account for 51.0% value share by 2025.
The global Companion Animal Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Companion Animal Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Companion Animal Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Companion Animal Vaccines in these regions.
This research report categorizes the global Companion Animal Vaccines market by top players/brands, region, type and end user. This report also studies the global Companion Animal Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Vetoquinol
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck
Merial

Market size by Product
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Market size by End User
Canine
Avian
Feline

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Companion Animal Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Companion Animal Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Companion Animal Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Companion Animal Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Companion Animal Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Companion Animal Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Companion Animal Vaccines Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Companion Animal Vaccines Market Size Growth Rate by Product
      • 1.4.2 Attenuated Live Vaccines
      • 1.4.3 Conjugate Vaccines
      • 1.4.4 Inactivated Vaccines
      • 1.4.5 Subunit Vaccines
      • 1.4.6 Toxoid Vaccines
      • 1.4.7 DNA Vaccines
      • 1.4.8 Recombinant Vaccines
    • 1.5 Market by End User
      • 1.5.1 Global Companion Animal Vaccines Market Size Growth Rate by End User
      • 1.5.2 Canine
      • 1.5.3 Avian
      • 1.5.4 Feline
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Companion Animal Vaccines Market Size
      • 2.1.1 Global Companion Animal Vaccines Revenue 2014-2025
      • 2.1.2 Global Companion Animal Vaccines Sales 2014-2025
    • 2.2 Companion Animal Vaccines Growth Rate by Regions
      • 2.2.1 Global Companion Animal Vaccines Sales by Regions
      • 2.2.2 Global Companion Animal Vaccines Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Companion Animal Vaccines Sales by Manufacturers
      • 3.1.1 Companion Animal Vaccines Sales by Manufacturers
      • 3.1.2 Companion Animal Vaccines Sales Market Share by Manufacturers
      • 3.1.3 Global Companion Animal Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.2 Companion Animal Vaccines Revenue by Manufacturers
      • 3.2.1 Companion Animal Vaccines Revenue by Manufacturers (2014-2019)
      • 3.2.2 Companion Animal Vaccines Revenue Share by Manufacturers (2014-2019)
    • 3.3 Companion Animal Vaccines Price by Manufacturers
    • 3.4 Companion Animal Vaccines Manufacturing Base Distribution, Product Types
      • 3.4.1 Companion Animal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Companion Animal Vaccines Product Type
      • 3.4.3 Date of International Manufacturers Enter into Companion Animal Vaccines Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Companion Animal Vaccines Sales by Product
    • 4.2 Global Companion Animal Vaccines Revenue by Product
    • 4.3 Companion Animal Vaccines Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Companion Animal Vaccines Breakdown Data by End User

    6 North America

    • 6.1 North America Companion Animal Vaccines by Countries
      • 6.1.1 North America Companion Animal Vaccines Sales by Countries
      • 6.1.2 North America Companion Animal Vaccines Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Companion Animal Vaccines by Product
    • 6.3 North America Companion Animal Vaccines by End User

    7 Europe

    • 7.1 Europe Companion Animal Vaccines by Countries
      • 7.1.1 Europe Companion Animal Vaccines Sales by Countries
      • 7.1.2 Europe Companion Animal Vaccines Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Companion Animal Vaccines by Product
    • 7.3 Europe Companion Animal Vaccines by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Companion Animal Vaccines by Countries
      • 8.1.1 Asia Pacific Companion Animal Vaccines Sales by Countries
      • 8.1.2 Asia Pacific Companion Animal Vaccines Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Companion Animal Vaccines by Product
    • 8.3 Asia Pacific Companion Animal Vaccines by End User

    9 Central & South America

    • 9.1 Central & South America Companion Animal Vaccines by Countries
      • 9.1.1 Central & South America Companion Animal Vaccines Sales by Countries
      • 9.1.2 Central & South America Companion Animal Vaccines Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Companion Animal Vaccines by Product
    • 9.3 Central & South America Companion Animal Vaccines by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Companion Animal Vaccines by Countries
      • 10.1.1 Middle East and Africa Companion Animal Vaccines Sales by Countries
      • 10.1.2 Middle East and Africa Companion Animal Vaccines Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Companion Animal Vaccines by Product
    • 10.3 Middle East and Africa Companion Animal Vaccines by End User

    11 Company Profiles

    • 11.1 Bayer
      • 11.1.1 Bayer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Bayer Companion Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Bayer Companion Animal Vaccines Products Offered
      • 11.1.5 Bayer Recent Development
    • 11.2 Vetoquinol
      • 11.2.1 Vetoquinol Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Vetoquinol Companion Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Vetoquinol Companion Animal Vaccines Products Offered
      • 11.2.5 Vetoquinol Recent Development
    • 11.3 Boehringer Ingelheim
      • 11.3.1 Boehringer Ingelheim Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Boehringer Ingelheim Companion Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Boehringer Ingelheim Companion Animal Vaccines Products Offered
      • 11.3.5 Boehringer Ingelheim Recent Development
    • 11.4 Ceva
      • 11.4.1 Ceva Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Ceva Companion Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Ceva Companion Animal Vaccines Products Offered
      • 11.4.5 Ceva Recent Development
    • 11.5 Eli Lilly
      • 11.5.1 Eli Lilly Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Eli Lilly Companion Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Eli Lilly Companion Animal Vaccines Products Offered
      • 11.5.5 Eli Lilly Recent Development
    • 11.6 Heska
      • 11.6.1 Heska Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Heska Companion Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Heska Companion Animal Vaccines Products Offered
      • 11.6.5 Heska Recent Development
    • 11.7 Merck
      • 11.7.1 Merck Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Merck Companion Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Merck Companion Animal Vaccines Products Offered
      • 11.7.5 Merck Recent Development
    • 11.8 Merial
      • 11.8.1 Merial Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Merial Companion Animal Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Merial Companion Animal Vaccines Products Offered
      • 11.8.5 Merial Recent Development

    12 Future Forecast

    • 12.1 Companion Animal Vaccines Market Forecast by Regions
      • 12.1.1 Global Companion Animal Vaccines Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Companion Animal Vaccines Revenue Forecast by Regions 2019-2025
    • 12.2 Companion Animal Vaccines Market Forecast by Product
      • 12.2.1 Global Companion Animal Vaccines Sales Forecast by Product 2019-2025
      • 12.2.2 Global Companion Animal Vaccines Revenue Forecast by Product 2019-2025
    • 12.3 Companion Animal Vaccines Market Forecast by End User
    • 12.4 North America Companion Animal Vaccines Forecast
    • 12.5 Europe Companion Animal Vaccines Forecast
    • 12.6 Asia Pacific Companion Animal Vaccines Forecast
    • 12.7 Central & South America Companion Animal Vaccines Forecast
    • 12.8 Middle East and Africa Companion Animal Vaccines Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Companion Animal Vaccines Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Companion Animal Vaccines . Industry analysis & Market Report on Companion Animal Vaccines is a syndicated market report, published as Global Companion Animal Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Companion Animal Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,120.00
      4,680.00
      6,240.00
      3,642.60
      5,463.90
      7,285.20
      615,966.00
      923,949.00
      1,231,932.00
      325,377.00
      488,065.50
      650,754.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report